Attention Deficit Hyperactivity Disorder Clinical Trials

4 recruiting

Frequently Asked Questions

Common questions about Attention Deficit Hyperactivity Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Developing Brain, Impulsivity and Compulsivity

Autism Spectrum DisorderAttention Deficit Hyperactivity DisorderObsessive-Compulsive Disorder+2 more
National Institute of Mental Health (NIMH)1,100 enrolled1 locationNCT04631042
Recruiting
Not Applicable

Improving ADHD Teen Driving - Virtual Reality

Attention Deficit Hyperactivity Disorder (ADHD)
Children's Hospital Medical Center, Cincinnati204 enrolled1 locationNCT06960980
Recruiting
Phase 2

Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression

Depression - Major Depressive DisorderAttention Deficit Hyperactivity Disorder (ADHD)
Prof. Dr. Frank Behrens105 enrolled2 locationsNCT06967857
Recruiting
Not Applicable

Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

Traumatic Brain InjurySchizophreniaSubstance Use Disorders+4 more
Massachusetts General Hospital600 enrolled1 locationNCT04296604
Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting
Phase 4

A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).

FatigueAttention Deficit Hyperactivity DisorderAttention Deficit Disorder
Rochester Center for Behavioral Medicine50 enrolled1 locationNCT06248229
Recruiting

The Relationship Between Emotion Regulation and Psychiatric Disorder in Youth

Adjustment DisorderAttention Deficit Hyperactivity Disorder (ADHD)Major Depressive Disorder+1 more
Chang Gung Memorial Hospital200 enrolled1 locationNCT06271954